These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 6766850)
1. Pharmacologic study of colchicine-amide. Li DH; Zhang SK; Hao ZG; Ma KS; Tan XR; Wang ZL; Li NK Chin Med J (Engl); 1980 Mar; 93(3):188-90. PubMed ID: 6766850 [No Abstract] [Full Text] [Related]
6. [Expression of transformation characters in colchicine-resistant tumor cells]. Kakpakova ES Biull Eksp Biol Med; 1983 Jul; 96(7):89-91. PubMed ID: 6871461 [TBL] [Abstract][Full Text] [Related]
7. [Changes in the sensitivity of cells towards hydrocortisone in the process of cancerogenesis]. Frankfurt OS Dokl Akad Nauk SSSR; 1968 May; 180(2):505-7. PubMed ID: 5745548 [No Abstract] [Full Text] [Related]
8. Cancer chemotherapy studies: cytoplasmic barrier in malignant epidermal cells against the effect of colchicine. An electron microscopic study in mice. Setälä K; Lindroos B; Nyyssönen O Acta Radiol Diagn (Stockh); 1966; ():Suppl 261:1-51. PubMed ID: 5964010 [No Abstract] [Full Text] [Related]
9. [Effect of heavy water (D20) on animal and plant cells and on microorganisms]. Den'ko EI Usp Sovrem Biol; 1970; 70(1):41-64. PubMed ID: 4924237 [No Abstract] [Full Text] [Related]
10. Inhibition of mitosis by glycopeptide dendrimer conjugates of colchicine. Lagnoux D; Darbre T; Schmitz ML; Reymond JL Chemistry; 2005 Jun; 11(13):3941-50. PubMed ID: 15861378 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic and toxicologic evaluation of thioproline: a proposed nontoxic inducer of reverse transformation. Newman RA; Hacker MP; McCormack JJ; Krakoff IH Cancer Treat Rep; 1980; 64(8-9):837-44. PubMed ID: 7448821 [TBL] [Abstract][Full Text] [Related]
12. [Effect of colchiceine amides on cells in vitro and in vivo]. LETTRE H Experientia; 1954 Jun; 10(6):271. PubMed ID: 13183074 [No Abstract] [Full Text] [Related]
13. High concentration of deoxycholic acid abrogates in vitro transformation of IEC6 intestinal cells by azoxymethane. Sasaki T; Shimura H; Sasahira T; Fujii K; Kuniyasu H J Exp Clin Cancer Res; 2005 Dec; 24(4):625-31. PubMed ID: 16471326 [TBL] [Abstract][Full Text] [Related]
14. [The effect of fractionated doses of N-colchicinamide on the mitosis of of mouse ascites tumor cells]. LETTRE H; BERGDOLT H Z Krebsforsch; 1953; 59(1):68-73. PubMed ID: 13103402 [No Abstract] [Full Text] [Related]
15. Clinical and experimental study of cancer (especially about the colchicine derivatives and the imido compounds). SATO K; AKAISHI K; HARADA K Gan; 1956 Dec; 47(3-4):370-2. PubMed ID: 13415044 [No Abstract] [Full Text] [Related]
17. An in vitro and in vivo investigation of three surface-active agents as modulators of cell proliferation. Tobler J; Watts MT; Fu JJ Cancer Res; 1980 Apr; 40(4):1173-80. PubMed ID: 7357547 [No Abstract] [Full Text] [Related]
18. Control of mitosis in mouse and hamster melanomata by means of the melanocyte chalone. Bullough WS; Laurence EB Eur J Cancer (1965); 1968 Dec; 4(6):607-15. PubMed ID: 5717957 [No Abstract] [Full Text] [Related]
19. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Davis PD; Dougherty GJ; Blakey DC; Galbraith SM; Tozer GM; Holder AL; Naylor MA; Nolan J; Stratford MR; Chaplin DJ; Hill SA Cancer Res; 2002 Dec; 62(24):7247-53. PubMed ID: 12499266 [TBL] [Abstract][Full Text] [Related]
20. [Changes in the nature of the hepatocyte proliferation in the liver and adenomatous nodes of mice in CC14-induced carcinogenesis]. Faktor VM; Poltoranina VS; Uryvaeva IV Biull Eksp Biol Med; 1982 Apr; 93(4):79-82. PubMed ID: 7082808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]